Vida Ventures Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Vida Ventures Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-97,978	Closed	-$2.51M	–	8
2023 Q3	$2.51M	Hold	97,978	–	–	3.89%	7
2023 Q2	$1.69M	Hold	97,978	–	–	2.21%	7
2023 Q1	$1.19M	Hold	97,978	–	–	1.63%	7
2022 Q4	$3.5M	Sell	97,978 -97,977	-50%	-$3.06M	4.7%	7
2022 Q3	$6.67M	Hold	195,955	–	–	5.99%	6
2022 Q2	$7.2M	Hold	195,955	–	–	6.08%	6
2022 Q1	$30M	Hold	195,955	–	–	17.46%	3
2021 Q4	$57.9M	Hold	195,955	–	–	21.66%	1
2021 Q3	$54.3M	Hold	195,955	–	–	15.57%	4
2021 Q2	$53.7M	Hold	195,955	–	–	13.47%	5
2021 Q1	$96.3M	Hold	195,955	–	–	24.33%	1
2020 Q4	$162M	Buy	+195,955	New	+$114M	33.19%	1

Other funds holding PRAX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vida Ventures Advisors's PRAX Position: Q4 2023 in Review

Vida Ventures Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2023, closing a stake of 97,978 shares — an estimated $2.51M sold.

Vida Ventures Advisors first reported a position in PRAX in Q4 2020 and held it in 12 quarters. The position peaked at $162M in Q4 2020. 60 funds tracked by Wall St. Rank hold PRAX as of Q4 2023.

Vida Ventures Advisors reported no remaining Praxis Precision Medicines position as of Q4 2023 after selling out during the quarter.
Vida Ventures Advisors sold 97,978 Praxis Precision Medicines shares in Q4 2023, an estimated $2.51M.
Vida Ventures Advisors first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 12 quarters.
Vida Ventures Advisors's Praxis Precision Medicines position peaked at $162M in Q4 2020.
60 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2023.

Based on Vida Ventures Advisors's 13F filing for Q4 2023, filed 5 Jan 2024.